p53 involvement in the pathogenesis of fatty liver disease.
about
Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitisThe role of the p53 tumor suppressor in metabolism and diabetesHepatic p63 regulates steatosis via IKKβ/ER stressExpression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver diseaseNonalcoholic fatty liver disease: molecular pathways and therapeutic strategiesTumor suppressor p53 regulates bile acid homeostasis via small heterodimer partner.Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance.A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolismLoss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformationA novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells.Cell cycle progression is an essential regulatory component of phospholipid metabolism and membrane homeostasis.Abdominal Irradiation Ameliorates Obesity in ob/ob Mice.MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH.Dietary selenium deficiency partially rescues type 2 diabetes-like phenotypes of glutathione peroxidase-1-overexpressing male mice.The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the LiverGreen tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling.The Hippo pathway, p53 and cholesterolKLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during Fasting.Metabolic regulation by p53 family members.Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.Apoptosis and cytokines in non-alcoholic steatohepatitis.Is p53 Involved in Tissue-Specific Insulin Resistance Formation?Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?p53 in liver pathologies-taking the good with the bad.MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.miRNA and cholesterol homeostasis.The Paradox of p53: What, How, and Why?Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.Lipid synthetic transcription factor SREBP-1a activates p21WAF1/CIP1, a universal cyclin-dependent kinase inhibitor.Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling.High Dietary Selenium Intake Alters Lipid Metabolism and Protein Synthesis in Liver and Muscle of Pigs.Atopic dermatitis causes lipid accumulation in the liver of NC/Nga mouse.Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis.p53 shades of Hippo.Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.Emerging Roles of p53 Family Members in Glucose Metabolism.Metformin, metabolic stress, and mitochondria. Focus on "A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells".
P2860
Q27022707-454F4F98-889F-496E-8539-0D886EB5AF58Q28079903-1C5964D1-1BB2-44ED-A8FC-6F92B2DF96EDQ33654494-60D1EC9F-58C6-491D-A8B8-219AE0AE6D44Q33869030-9850A45C-3AC5-44D3-A0C6-0E571996F51BQ34657286-94C18FDD-20BC-4DAF-8DC7-54098D681624Q35134152-069D9C3E-BC26-4F6D-994B-87618263D6A6Q35674559-EDED7825-3ADB-49DB-8A0F-77BD5953668CQ35776935-0501AFB4-46D8-45BA-9A17-AAC5362130CBQ35835250-FBE6A73A-344C-4C46-A3A3-9ABAA9C1262BQ36114705-53760156-A240-4B78-83A7-9DD601E249BFQ36122257-80E9CC7E-E063-4D69-932A-BF97918506C1Q36245699-ED92AF64-C881-4D44-B508-0A2566EC6370Q36329460-14BACE4C-0D10-4C7D-95BA-C34AB8EFDE34Q36398560-A5603989-E16E-41A9-A859-4EEBC26E1372Q37120247-D65EAB0D-80F8-45EC-8076-797335DAD77CQ37154069-248455CA-3287-4467-B931-BB510A3DE9C8Q37216964-DBD1A075-AE4B-464E-93E6-D70577EB1378Q37273150-3BB15AAF-0257-4C78-AE8A-1AF9A42C6774Q37298047-1BEB2D81-B3F3-4BA6-B9AB-248FF805F806Q37375389-E7D64182-2B11-4651-9D1E-17C5772F3A1FQ37396965-5FB858B5-A149-4711-B625-6988FEC45A6EQ37615064-A8A6FADD-85A6-4D2A-B9E7-8E9425DF483CQ37863134-1462D4E4-3DCE-4988-9EE2-8F2B36B6F2CBQ38268953-61B1ABD6-487A-4F13-8EB8-38A5B448264DQ38297030-00ABD3DE-7F4E-4154-82CE-26DC8DAE8C7EQ38700512-C39A1519-3AE3-4CC8-B920-E552B9EA9F54Q38896065-8F546EAF-C25A-4898-8639-C2F1DA670480Q39232535-DEBBED71-45DC-4A73-8F4F-3534D122CC93Q39659874-3987B369-5382-485C-90E4-165F11ACFDFCQ39659924-7F25855B-0D89-44CF-AE97-8123DB1C6BF6Q40366577-5380728E-0F25-49FC-883B-FDB69DE07F95Q40474758-10008BA1-656B-4C25-A208-8B53D33366D6Q41209547-4C440931-F392-4AFA-9E94-457FB5D5C7E0Q42099360-C3888A81-12F0-454A-AB4B-F05D1D9425A7Q47228271-CD573A12-64CA-4218-B356-B1D217D28240Q47850800-DB9D58DF-E22C-4E68-8502-0D16B12CC46AQ50280266-237E483B-34F3-4B50-AA6D-68F56B6D23BEQ51761242-8ED5C917-6563-44E5-ABD1-C64378568E20Q52727888-3B305AD8-4948-4340-8781-88FCAD21B4C1Q54521803-B85BB818-7C4F-40BE-A88E-1143E8A77B3A
P2860
p53 involvement in the pathogenesis of fatty liver disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
p53 involvement in the pathogenesis of fatty liver disease.
@en
type
label
p53 involvement in the pathogenesis of fatty liver disease.
@en
prefLabel
p53 involvement in the pathogenesis of fatty liver disease.
@en
P2093
P2860
P356
P1476
p53 involvement in the pathogenesis of fatty liver disease
@en
P2093
Hiroaki Okazaki
Hitoshi Shimano
Jun-ichi Osuga
Ken Ohashi
Kenji Harada
Motohiro Sekiya
Nobuhiro Yamada
Noriyuki Inoue
Ryozo Nagai
Sachiko Okazaki
P2860
P304
20571-20575
P356
10.1074/JBC.M400884200
P407
P577
2004-02-25T00:00:00Z